Cambridge Advisors’s Exelon EXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-7,156
Closed -$217K 144
2018
Q2
$217K Sell
7,156
-2,061
-22% -$59K 0.08% 133
2018
Q1
$256K Sell
9,217
-531
-5% -$14.3K 0.09% 120
2017
Q4
$274K Buy
9,748
+27
+0.3% +$776 0.1% 119
2017
Q3
$261K Buy
9,721
+29
+0.3% +$776 0.1% 118
2017
Q2
$249K Buy
9,692
+32
+0.3% +$814 0.1% 117
2017
Q1
$248K Sell
9,660
-136
-1% -$3.47K 0.1% 116
2016
Q4
$248K Sell
9,796
-388
-4% -$9.2K 0.11% 116
2016
Q3
$242K Sell
10,184
-3,718
-27% -$93.4K 0.11% 117
2016
Q2
$361K Buy
13,902
+31
+0.2% +$767 0.17% 100
2016
Q1
$355K Sell
13,871
-250
-2% -$5.6K 0.16% 99
2015
Q4
$280K Sell
14,121
-1,029
-7% -$20.9K 0.16% 111
2015
Q3
$321K Buy
15,150
+91
+0.6% +$2.05K 0.19% 101
2015
Q2
$337K Buy
15,059
+12,535
+497% +$300K 0.19% 96
2015
Q1
$298K Sell
2,524
-13,481
-84% -$334K 0.17% 101
2014
Q4
$423K Buy
+16,005
New +$411K 0.26% 79

Other funds holding EXC

Cambridge Advisors's EXC Position: Q3 2018 in Review

Cambridge Advisors sold out of Exelon (EXC) in Q3 2018, closing a stake of 7,156 shares — an estimated $217K sold.

Cambridge Advisors first reported a position in EXC in Q4 2014 and held it in 15 quarters. The position peaked at $423K in Q4 2014. 915 funds tracked by Wall St. Rank hold EXC as of Q3 2018.

  • Cambridge Advisors reported no remaining Exelon position as of Q3 2018 after selling out during the quarter.
  • Cambridge Advisors sold 7,156 Exelon shares in Q3 2018, an estimated $217K.
  • Cambridge Advisors first reported a position in Exelon in Q4 2014 and held it in 15 quarters.
  • Cambridge Advisors's Exelon position peaked at $423K in Q4 2014.
  • 915 funds tracked by Wall St. Rank held Exelon as of Q3 2018.

Based on Cambridge Advisors's 13F filing for Q3 2018, filed 24 Oct 2018.